Explore the latest advancements in rheumatology biosimilars, including FDA approvals, patient switching trends, and ...

To read all of these articles and more, visit centerforbiosimilars.com.

The debate over the Biosimilar Red Tape Elimination Act raises critical concerns about FDA standards, physician trust, and ...

Pediatric infliximab biosimilar use has risen significantly, reflecting evolving treatment patterns in inflammatory bowel ...

Celltrion's FDA approval of Steqeyma enhances pediatric psoriasis treatment, offering flexible dosing options for children ...

Josh Canavan, PharmD, RazorMetrics, and Chris O'Dell, Turquoise Health, explain that widespread biosimilar adoption requires addressing patient and provider education gaps through pharmacists and ...

Number 5: The new data were collected to fulfill the FDA's requirements to designate adalimumab-fkjp (Hulio) as ...

"Escaping the Void: All Things Biosimilars With Craig & G" with cohosts Craig Burton, executive director of the Biosimilars Council, and Giuseppe (G) Randazzo, senior vice president of sciences and ...